Flavanone metabolism in healthy and tumor-bearing rats

M Silberberg1, A Gil-Izquierdo, L Combaret

  • 1Unité des Maladies Métaboliques et Micronutriments, Inra, Centre de Recherche de Clermont-Ferrant/Theix, 63122 Saint-Genès-Champanelle, France. msilber@clermont.inra.fr

Insights

Citrus flavanones, like naringin, are metabolized differently in tumor-bearing rats compared to healthy ones. Cancer may reduce the bioavailability of these beneficial plant compounds.

Area of Science:

  • Nutritional biochemistry
  • Pharmacokinetics
  • Cancer research

Background:

  • Flavanones, abundant polyphenols in citrus fruits, are linked to protective effects against cardiovascular diseases and cancer.
  • Understanding the metabolism and bioavailability of flavanones is crucial for their potential health benefits.

Purpose of the Study:

  • To investigate the metabolism of naringin in healthy and tumor-bearing rats.
  • To compare the bioavailability of flavanones in different physiological states.

Main Methods:

  • Rats (healthy and tumor-bearing) were fed a semi-synthetic diet containing 0.5% naringin for 7 days.
  • Flavanone metabolites in plasma, liver, kidney, and urine were analyzed using tandem mass spectrometry.
  • In vivo hydroxylation of flavanones was studied.

Main Results:

  • Naringenin conjugates (glucuronides) constituted up to 98% of plasma flavanones.
  • Hesperetin and isosakuranetin were detected as aglycones, representing 2% of plasma flavanones.
  • Total naringenin metabolite concentrations were significantly lower in tumor-bearing rats (10.6 microM) compared to healthy rats (17.3 microM) 6 hours post-meal.

Conclusions:

  • The in vivo hydroxylation of flavanones was observed for the first time.
  • Metabolite profiles were similar across healthy and tumor-bearing rats, and across different tissues and urine.
  • Lower flavanone concentrations in tumor-bearing rats suggest that cancer may impair flavonoid bioavailability.